EJMK Ventures’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
EJMK Ventures's ABBV Position: Q3 2026 in Review
EJMK Ventures increased its AbbVie (ABBV) stake by 3.3% in Q3 2026, buying an estimated $64.6K and bringing the position to 7,799 shares worth $2.04M. The position accounts for 0.86% of the portfolio, ranked #24.
EJMK Ventures first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,273 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- EJMK Ventures held 7,799 shares of AbbVie worth $2.04M as of Q3 2026.
- EJMK Ventures bought 252 AbbVie shares in Q3 2026, an estimated $64.6K.
- AbbVie made up 0.86% of EJMK Ventures's portfolio in Q3 2026, its #24 holding.
- EJMK Ventures first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
- 4,273 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.